Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-DOPA and as chronic treatment
- 1 October 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 264 (2) , 117-123
- https://doi.org/10.1016/0014-2999(94)00446-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of talipexole on motor behavior in normal and MPTP-treated common marmosetsEuropean Journal of Pharmacology, 1993
- Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptorsMovement Disorders, 1993
- MPTP mechanisms of neurotoxicity and their implications for Parkinson's diseaseEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Drugs acting on brain dopamine receptors: A conceptual re-evaluation five years after the first selective D-1 antagonistPharmacology & Therapeutics, 1989
- Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysisEuropean Journal of Pharmacology, 1988
- Stimulation of D1dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B‐HT 920 on postsynaptic dopamine receptorsActa Physiologica Scandinavica, 1988
- Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulationEuropean Journal of Pharmacology, 1988
- BHT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: Electrophysiological and behavioral evidenceLife Sciences, 1988
- Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in ratsEuropean Journal of Pharmacology, 1987
- Investigation into different types of post- and presynaptic α-adrenoceptors at cardiovascular sites in ratsEuropean Journal of Pharmacology, 1980